バイオインピーダンスアナライザ市場：タイプ別（単一、マルチ、デュアル周波数）、モダリティ別（有線、ワイヤレス）、用途別（セグメント別身体測定、全身測定）、エンドユーザー別（フィットネスクラブ、ホームユーザー、病院）、地域別-2028年までの世界予測

Bioimpedance Analyzers Market by Type (Single, Multi & Dual Frequency), Modality (Wired, Wireless), Application (Segmental Body Measurement, Whole Body Measurement), End User (Fitness Clubs, Home Users, Hospitals), & Region- Global Forecast to 2028

バイオインピーダンスアナライザの世界市場は、2023年の5億6,400万米ドルから2028年には9億2,700万米ドルに達すると予測され、予測期間中の年平均成長率は10.4%である。この市場の成長は、政府による健康的なライ... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年8月2日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	166	158	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

バイオインピーダンスアナライザの世界市場は、2023年の5億6,400万米ドルから2028年には9億2,700万米ドルに達すると予測され、予測期間中の年平均成長率は10.4%である。この市場の成長は、政府による健康的なライフスタイルの推進、フィットネスやウェルネスセンターの増加、栄養士や栄養士の増加などが主な要因である。しかし、業務用バイオインピーダンス・アナライザーのコスト高が、バイオインピーダンス・アナライザー市場の成長を抑制している。
"予測期間中、バイオインピーダンスアナライザ市場において、製品別ではマルチ周波数バイオインピーダンスアナライザセグメントが最も高い市場シェアを占めた。"
製品セグメントに基づき、バイオインピーダンスアナライザ市場は、マルチ周波数、単一周波数、デュアル周波数のバイオインピーダンスアナライザに分類される。2022年には、マルチ周波数バイオインピーダンスアナライザセグメントが製品市場を支配した。また、このセグメントは予測期間中に最も高いCAGRで成長すると推定されている。この大きなシェアは、データ分析を強化するためのウェアラブルデバイスやイメージング技術など、他の技術との統合によるものである。
"フィットネスクラブ＆ウェルネスセンターが予測期間中最も高いCAGRを占めた"
エンドユーザーに基づき、生体インピーダンスアナライザ市場は病院、フィットネスクラブ&ウェルネスセンター、ホームユーザー、その他のエンドユーザーに区分される。2022年の生体インピーダンスアナライザ市場は、フィットネスクラブ&ウェルネスセンターセグメントが支配的であった。このセグメントは予測期間中に最も高いCAGRで成長すると予測されている。ジムやウェルネスセンターの増加、健康とフィットネスに対する意識の高まりが市場成長を促進する主な要因である。
"予測期間中、バイオインピーダンスアナライザ市場において、地域別では北米セグメントが最も高い市場シェアを占めた。"
バイオインピーダンスアナライザの世界市場は、地域別に北米、欧州、アジア太平洋、その他の地域に分類される。北米は予測期間中、高い市場シェアが見込まれる。技術的に先進的な生体インピーダンス分析装置の存在と、健康的なライフスタイルの普及が、生体インピーダンス分析装置市場の成長を支えている。
供給側一次インタビューの企業タイプ別、呼称別、地域別内訳
- 企業タイプ別ティア1（30%）、ティア2（48%）、ティア3（22）
- 役職別Cレベル(28%)、ディレクターレベル(33%)、その他(39%)
- 地域別北米 (21%)、アジア太平洋 (34%)、ヨーロッパ (30%)、RoW (15%)

主な企業は、オムロン（日本）、タニタ（日本）、InBody（韓国）、RJL Systems（米国）、seca GmbH & Co.KG（ドイツ）、EVOLT 360（オーストラリア）、SELVAS Healthcare（韓国）、Charder Electronic Co.Ltd.（中国）、Fook Tin Co.(Ltd.（中国）、Fook Tin Group Holdings Ltd.（中国）、Bodystat Ltd.(中国）、Bodystat Ltd.(英国）、Maltron International（英国）、Microlife（スイス）、BioTekna（イタリア）、Withings（フランス）、Biodynamics Corporation（米国）、Akern（イタリア）、Xiaomi（中国）、Sino-Hero（Shenzhen）Bio-Medical Electronics Co.(中国）、LUMSAIL Industrial Inc.（中国）、Microlife（スイス）、Guangzhou Beautylife Electronic Technology Co.(中国)、BioparHom (フランス)、Sonka Medical Technology Co., Limited (中国)、NUMED s.a.r.l. (バダロ)、Wunder Sa.Bi.Srl.（イタリア）、Shenzhen Yolanda Technology Co.Ltd（中国）、Bodivis（Tongfang Health Technology）（中国）。

調査範囲
この調査レポートは、生体インピーダンス分析装置市場を製品、モダリティ、使用タイプ、用途、エンドユーザー、地域別に分類しています。バイオインピーダンスアナライザ市場の成長に影響を与える促進要因、阻害要因、課題、機会などの主要要因に関する詳細情報を網羅しています。主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、合意などに関する洞察を提供しています。バイオインピーダンスアナライザー市場に関連する新製品・サービスの発表、合併・買収、最近の動向。バイオインピーダンスアナライザー市場のエコシステムにおける今後の新興企業の競合分析もカバーしています。

レポート購入の主なメリット
本レポートは、バイオインピーダンスアナライザ市場全体とサブセグメントにおける収益数の最も近い近似値に関する情報を提供し、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、ステークホルダーが競合状況を理解し、より深い洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。
本レポートでは、以下のポイントに関する洞察を提供しています：
- 生体インピーダンス分析装置市場の成長に影響を与える主要な促進要因、阻害要因、機会、課題の分析
- 製品開発/イノベーション：バイオインピーダンスアナライザー市場における今後の技術、研究開発活動、新製品・新サービスの発表に関する詳細な洞察。
- 市場開発：有利な市場に関する包括的な情報 - 当レポートでは、さまざまな地域の生体インピーダンス分析装置市場を分析しています。
- 市場の多様化：バイオインピーダンスアナライザー市場における新製品・サービス、未開拓の地域、最近の開発、投資に関する詳細な情報
- 競合評価：オムロン株式会社（日本）、株式会社タニタ（日本）、InBody社（韓国）、RJL Systems社（米国）、Seca GmbH & Co.KG（ドイツ）など、バイオインピーダンスアナライザーの市場戦略について掲載しています。

ページTOPに戻る

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
TABLE 1 INCLUSIONS AND EXCLUSIONS 23
1.3 STUDY SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 REGIONS COVERED 24
1.3.3 YEARS CONSIDERED 25
1.4 CURRENCY 25
1.5 STAKEHOLDERS 25
1.6 SUMMARY OF CHANGES 26
1.7 LIMITATIONS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 1 BIOIMPEDANCE ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Secondary sources 29
2.1.2 PRIMARY DATA 30
FIGURE 2 PRIMARY SOURCES 30
TABLE 2 KEY DATA FROM PRIMARY SOURCES 31
2.1.2.1 Key industry insights 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 33
2.2 MARKET SIZE ESTIMATION 33
2.2.1 BOTTOM-UP APPROACH 34
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 34
2.2.1.1 Growth forecast 35
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 35
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 36
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 37
FIGURE 8 DATA TRIANGULATION METHODOLOGY 37
2.4 MARKET SHARE ANALYSIS 37
2.5 STUDY ASSUMPTIONS 38
2.6 RISK ASSESSMENT 38
2.7 RECESSION IMPACT ANALYSIS 38

3 EXECUTIVE SUMMARY 39
FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION) 39
FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2023 VS. 2028 (USD BILLION) 40
FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2023 VS. 2028 (USD BILLION) 40
FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD BILLION) 41
FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2023 VS. 2028 (USD BILLION) 42
FIGURE 14 BIOIMPEDANCE ANALYZERS MARKET: GEOGRAPHICAL SNAPSHOT 43
4 PREMIUM INSIGHTS 44
4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW 44
FIGURE 15 INCREASED PREVALENCE OF OBESITY TO DRIVE BIOIMPEDANCE ANALYZERS MARKET 44
4.2 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY (2022) 45
FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS ACCOUNTED FOR LARGEST SHARE IN 2022 45
4.3 REGIONAL GROWTH OPPORTUNITIES IN BIOIMPEDANCE ANALYZERS MARKET 46
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
4.4 BIOIMPEDANCE ANALYZERS MARKET: REGIONAL MIX 47
FIGURE 18 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD 47
4.5 BIOIMPEDANCE ANALYZERS MARKET: DEVELOPED VS. EMERGING ECONOMIES 47
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 20 BIOIMPEDANCE ANALYZERS MARKET DYNAMICS 48
5.2.1 DRIVERS 49
5.2.1.1 Increasing prevalence of lifestyle diseases 49
5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles 49
5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers 50
5.2.2 RESTRAINTS 50
5.2.2.1 Presence of alternative methods 50
5.2.2.2 High cost of analyzers 51
TABLE 3 BIOIMPEDANCE ANALYZERS: AVERAGE PRICE RANGE, BY COMPANY 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Emerging markets across Asia Pacific and Latin America 51
5.2.3.2 Integration with wearable devices 52
5.2.4 CHALLENGES 52
5.2.4.1 Inconsistency in accuracy of different bioimpedance analyzers 52
5.3 SUPPLY CHAIN ANALYSIS 53
FIGURE 21 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 54
5.4 VALUE CHAIN ANALYSIS 54
FIGURE 22 BIOIMPEDANCE ANALYZERS MARKET: VALUE CHAIN ANALYSIS 54
5.5 ECOSYSTEM ANALYSIS 55
FIGURE 23 BIOIMPEDANCE ANALYZERS MARKET: ECOSYSTEM ANALYSIS 55
5.5.1 ROLE IN ECOSYSTEM 56
FIGURE 24 BIOIMPEDANCE ANALYZERS MARKET ECOSYSTEM: KEY PLAYERS 56
5.6 REGULATORY LANDSCAPE 57
5.6.1 NORTH AMERICA 57
5.6.1.1 US 57
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 57
5.6.1.2 Canada 58
TABLE 5 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 58
5.6.2 EUROPE 58
5.6.3 ASIA PACIFIC 59
5.6.3.1 Japan 59
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 59
5.6.3.2 China 60
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 60
5.6.3.3 India 60
TABLE 8 REGULATORY AUTHORITIES 61
5.7 PORTER’S FIVE FORCES ANALYSIS 62
5.7.1 THREAT OF NEW ENTRANTS 62
5.7.2 BARGAINING POWER OF SUPPLIERS 62
5.7.3 BARGAINING POWER OF BUYERS 62
5.7.4 INTENSITY OF COMPETITIVE RIVALRY 62
5.7.5 THREAT OF SUBSTITUTES 62
5.8 PATENT ANALYSIS 63
FIGURE 25 PATENT ANALYSIS FOR BIOIMPEDANCE ANALYZERS (JANUARY 2013–NOVEMBER 2022) 63
5.9 TRADE ANALYSIS 64
TABLE 9 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION) 64
TABLE 10 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION) 64
5.10 TECHNOLOGY ANALYSIS 65
5.11 PRICING ANALYSIS 66
TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 66
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.12.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS 67
FIGURE 26 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS 67
6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT 68
6.1 INTRODUCTION 69
TABLE 12 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 69
6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS 69
6.2.1 ACCURACY AND PRECISION TO DRIVE MARKET 69
TABLE 13 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY 70
TABLE 14 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 70
6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS 71
6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE MARKET 71
TABLE 15 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY 71
TABLE 16 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 71
6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS 72
6.4.1 SUITABILITY FOR ADVANCED CLINICAL AND RESEARCH APPLICATIONS TO FAVOR GROWTH 72
TABLE 17 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY 72
TABLE 18 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 72
7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY 73
7.1 INTRODUCTION 74
TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 74
7.2 WIRELESS BIOIMPEDANCE ANALYZERS 74
7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS TO HOLD LARGEST MARKET SHARE 74
TABLE 20 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 75
7.3 WIRED BIOIMPEDANCE ANALYZERS 75
7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE DEMAND 75
TABLE 21 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 75
8 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE 76
8.1 INTRODUCTION 77
TABLE 22 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION) 77
8.2 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS 77
8.2.1 GROWING NUMBER OF FITNESS & WELLNESS CENTERS TO DRIVE MARKET 77
TABLE 23 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 78
8.3 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS 78
8.3.1 GROWING AWARENESS OF FITNESS AND TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE MARKET 78
TABLE 24 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 79
9 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION 80
9.1 INTRODUCTION 81
TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 81
9.2 SEGMENTAL BODY MEASUREMENT 81
9.2.1 RISING EMPHASIS ON MONITORING TRAINING EFFECTIVENESS TO BOOST ADOPTION 81
TABLE 26 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION) 82
9.3 WHOLE-BODY MEASUREMENT 82
9.3.1 GROWING USE OF WHOLE-BODY ANALYZERS TO DRIVE MARKET 82
TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION) 82
10 BIOIMPEDANCE ANALYZERS MARKET, BY END USER 83
10.1 INTRODUCTION 84
TABLE 28 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 84
10.2 FITNESS CLUBS & WELLNESS CENTERS 84
10.2.1 FITNESS CLUBS & WELLNESS CENTERS TO DOMINATE END-USER MARKET 84
FIGURE 27 US: NUMBER OF HEALTH CLUBS, 2012–2022 85
TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, 2021–2028 (USD MILLION) 85
10.3 HOME USERS 86
10.3.1 AFFORDABILITY AND CONVENIENCE TO DRIVE ANALYZER ADOPTION 86
TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2021–2028 (USD MILLION) 86
10.4 HOSPITALS & CLINICS 87
10.4.1 NEED TO MONITOR NUTRITIONAL, HYDRATION STATES AND OTHER PARAMETERS TO BOOST ADOPTION 87
TABLE 31 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION) 87
10.5 OTHER END USERS 88
TABLE 32 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 88
11 BIOIMPEDANCE ANALYZERS MARKET, BY REGION 89
11.1 INTRODUCTION 90
TABLE 33 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 90
11.2 NORTH AMERICA 91
FIGURE 28 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT 91
TABLE 34 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 35 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 92
TABLE 36 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 92
TABLE 37 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION) 93
TABLE 38 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93
TABLE 39 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 93
11.2.1 RECESSION IMPACT 94
11.2.2 US 94
11.2.2.1 Rising obesity rate and interest in health clubs & fitness centers to drive market 94
TABLE 40 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 95
TABLE 41 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 95
TABLE 42 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 43 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 96
11.2.3 CANADA 96
11.2.3.1 High prevalence of obesity in Canada to support market growth 96
TABLE 44 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 97
TABLE 45 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 97
TABLE 46 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
TABLE 47 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 98
11.3 EUROPE 98
TABLE 48 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 49 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 99
TABLE 50 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 99
TABLE 51 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION) 99
TABLE 52 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 100
TABLE 53 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 100
11.3.1 RECESSION IMPACT 100
11.3.2 GERMANY 100
11.3.2.1 Germany to hold largest market share in Europe 100
TABLE 54 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 101
TABLE 55 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 101
TABLE 56 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 102
TABLE 57 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 102
11.3.3 UK 102
11.3.3.1 Rising incidence of kidney disorders to drive market 102
TABLE 58 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 103
TABLE 59 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 103
TABLE 60 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
TABLE 61 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 104
11.3.4 FRANCE 104
11.3.4.1 Increasing obese population and rising prevalence of metabolic disorders to drive market 104
TABLE 62 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 105
TABLE 63 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 105
TABLE 64 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 105
TABLE 65 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 106
11.3.5 REST OF EUROPE 106
TABLE 66 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 107
TABLE 67 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 107
TABLE 68 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 107
TABLE 69 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 108

11.4 ASIA PACIFIC 108
11.4.1 RECESSION IMPACT 108
FIGURE 29 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT 109
TABLE 70 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 71 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110
TABLE 72 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 111
TABLE 73 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION) 111
TABLE 74 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 111
TABLE 75 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 112
11.4.2 JAPAN 112
11.4.2.1 Government initiatives to drive market 112
TABLE 76 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 113
TABLE 77 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 113
TABLE 78 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
TABLE 79 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 114
11.4.3 CHINA 114
11.4.3.1 China to register highest CAGR in APAC market 114
TABLE 80 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 115
TABLE 81 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 115
TABLE 82 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 115
TABLE 83 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 116
11.4.4 AUSTRALIA 116
11.4.4.1 High prevalence of obesity to drive market 116
TABLE 84 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 117
TABLE 85 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 117
TABLE 86 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 117
TABLE 87 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 118
11.4.5 PHILIPPINES 118
11.4.5.1 Favorable government initiatives to support market growth 118
TABLE 88 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 118
TABLE 89 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 119
TABLE 90 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 91 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 119
11.4.6 TAIWAN 120
11.4.6.1 Increasing incidence of lifestyle diseases to drive market 120
TABLE 92 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 120
TABLE 93 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 120
TABLE 94 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121
TABLE 95 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 121
11.4.7 REST OF ASIA PACIFIC 121
TABLE 96 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 122
TABLE 97 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 122
TABLE 98 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
TABLE 99 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 123
11.5 REST OF THE WORLD 123
11.5.1 RECESSION IMPACT 123
TABLE 100 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 101 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION) 124
TABLE 102 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 103 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 125
12 COMPETITIVE LANDSCAPE 126
12.1 OVERVIEW 126
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 126
TABLE 104 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 126
12.3 MARKET SHARE ANALYSIS 127
TABLE 105 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION 127
12.4 COMPANY EVALUATION MATRIX (2022) 128
12.4.1 STARS 128
12.4.2 EMERGING LEADERS 128
12.4.3 PERVASIVE PLAYERS 128
12.4.4 PARTICIPANTS 128
FIGURE 30 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX, 2022 129
12.5 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 130
12.5.1 PROGRESSIVE COMPANIES 130
12.5.2 STARTING BLOCKS 130
12.5.3 RESPONSIVE COMPANIES 130
12.5.4 DYNAMIC COMPANIES 130
FIGURE 31 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 131
12.6 COMPETITIVE BENCHMARKING 132
TABLE 106 BIOIMPEDANCE ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 132
TABLE 107 PRODUCT FOOTPRINT ANALYSIS 133
TABLE 108 REGIONAL FOOTPRINT ANALYSIS 134
TABLE 109 BIOIMPEDANCE ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SMES 135
12.7 COMPETITIVE SCENARIO 135
12.7.1 PRODUCT LAUNCHES 135
TABLE 110 PRODUCT LAUNCHES, 2020–2023 135
12.7.2 DEALS 136
TABLE 111 DEALS, 2020–2023 136
12.7.3 OTHER DEVELOPMENTS 136
TABLE 112 OTHER DEVELOPMENTS, 2020–2023 136
13 COMPANY PROFILES 137
13.1 KEY PLAYERS 137
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 OMRON CORPORATION 137
TABLE 113 OMRON CORPORATION: BUSINESS OVERVIEW 137
FIGURE 32 OMRON CORPORATION: COMPANY SNAPSHOT (2022) 138
13.1.2 TANITA CORPORATION 140
TABLE 114 TANITA CORPORATION: BUSINESS OVERVIEW 140
13.1.3 INBODY CO., LTD. 143
TABLE 115 INBODY CO., LTD.: BUSINESS OVERVIEW 143
TABLE 116 INBODY CO., LTD.: DEALS 144
TABLE 117 INBODY CO., LTD.: OTHER DEVELOPMENTS 144
13.1.4 RJL SYSTEMS, INC. 145
TABLE 118 RJL SYSTEMS, INC.: BUSINESS OVERVIEW 145
13.1.5 SECA GMBH & CO. KG 147
TABLE 119 SECA GMBH & CO. KG: BUSINESS OVERVIEW 147
13.1.6 EVOLT 360 149
TABLE 120 EVOLT 360: BUSINESS OVERVIEW 149
13.1.7 SELVAS HEALTHCARE (FORMERLY JAWON MEDICAL) 150
TABLE 121 SELVAS HEALTHCARE: BUSINESS OVERVIEW 150
13.1.8 FOOK TIN TECHNOLOGIES LTD. 151
TABLE 122 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW 151
13.1.9 BODYSTAT LTD. 152
TABLE 123 BODYSTAT LTD.: BUSINESS OVERVIEW 152
TABLE 124 BODYSTAT LTD.: PRODUCT LAUNCHES 152
13.1.10 CHARDER ELECTRONIC CO., LTD. 153
TABLE 125 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW 153
13.1.11 MALTRON INTERNATIONAL 154
TABLE 126 MALTRON INTERNATIONAL: BUSINESS OVERVIEW 154
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS 155
13.2.1 BIOTEKNA 155
13.2.2 BIODYNAMICS CORPORATION 155
13.2.3 AKERN 156
13.2.4 WITHINGS 156
13.2.5 XIAOMI 157
13.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD. 157
13.2.7 LUMSAIL INDUSTRIAL INC. 158
13.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD. 158
13.2.9 BIOPARHOM 159
13.2.10 MICROLIFE 159
13.2.11 SONKA MEDICAL TECHNOLOGY CO., LIMITED 160
13.2.12 NUMED S.A.R.L. 160
13.2.13 WUNDER SA.BI. SRL. 161
13.2.14 SHENZHEN YOLANDA TECHNOLOGY CO., LTD 161
13.2.15 BODIVIS (TONGFANG HEALTH TECHNOLOGY CO., LTD.) 162
14 APPENDIX 163
14.1 DISCUSSION GUIDE 163
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 167
14.3 CUSTOMIZATION OPTIONS 169
14.4 RELATED REPORTS 169
14.5 AUTHOR DETAILS 170

ページTOPに戻る

Table of Contents

Summary

The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven by the promotion of healthy lifestyles by the government, growing fitness and wellness centers, and an increase in the number of nutritionists and dieticians. However, However, issues related high cost of professional-grade bioimpedance analyzers restrain the growth of the bioimpedance analyzers market.
“The multi-frequency bioimpedance analyzers segment accounted for the highest market share in the bioimpedance analyzers market, by product, during the forecast period.”
Based on the product segment, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to their integration with other technologies, such as wearable devices or imaging techniques for enhancing data analysis.
“Fitness clubs & wellness centers accounted for the highest CAGR during the forecast period.”
Based on end users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs & wellness centers, home users, and other end users. The fitness clubs & wellness centers segment dominated the bioimpedance analyzers market in 2022. This segment is expected to grow at the highest CAGR during the forecast period. The growing gyms and wellness centers and the rising awareness about health & fitness are the key factors driving market growth.
“The North America segment accounted for the highest market share in the bioimpedance analyzers market, by region, during the forecast period.”
Based on the region, the global bioimpedance analyzers market is categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced bioimpedance analyzers and the increasing adoption of healthy lifestyles are supporting the growth of the bioimpedance analyzers market.
Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
• By Designation: C-level (28%), Director-level (33%), and Others (39%)
• By Region: North America (21%), Asia- Pacific (34%), Europe (30%), and RoW (15%)

Prominent companies include OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), seca GmbH & Co. KG (Germany), EVOLT 360 (Australia), SELVAS Healthcare (South Korea), Charder Electronic Co. Ltd. (China), Fook Tin Group Holdings Ltd. (China), Bodystat Ltd. (UK), Maltron International (UK), Microlife (Switzerland), BioTekna (Italy), Withings (France), Biodynamics Corporation (US), Akern (Italy), Xiaomi (China), Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd. (China), LUMSAIL Industrial Inc. (China), Microlife (Switzerland), Guangzhou Beautylife Electronic Technology Co., Ltd. (China), BioparHom (France), Sonka Medical Technology Co., Limited (China), NUMED s.a.r.l. (Badaro), Wunder Sa.Bi. Srl. (Italy), Shenzhen Yolanda Technology Co., Ltd (China), and Bodivis (Tongfang Health Technology) (China).

Research Coverage
This research report categorizes the bioimpedance analyzers market by product, modality, usage type, application, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioimpedance analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the bioimpedance analyzers market. Competitive analysis of upcoming startups in the bioimpedance analyzers market ecosystem is covered in this report.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bioimpedance analyzers market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the bioimpedance analyzers market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioimpedance analyzers market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the bioimpedance analyzers market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the bioimpedance analyzers market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), Seca GmbH & Co. KG (Germany), among others in the bioimpedance analyzers market strategies.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（bioimpedance analyzers）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（bioimpedance analyzers）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?